However, combination treatment with Rosc and anti‐PD‐1 strongly inhibited tumor growth and metastatic progression (Figure 6A–C), while the treated mice showed a slight increase in body weight (Figure S6E, Supporting Information). The gene discussed is PDCD1; the disease is neoplasm.